Alj Regional Hldg (OOTC:ALJJ) ($3.93) – ALJJ’s shares took a wild ride after the company’s annual report was released on December 31, 2014. The release was accompanied by a press release that cited full year EPS of $.48 and $.20 for […]
We may look to add to our long position of PFHO ($45.00) For a while, GeoInvesting has been following Pacific Healthcare Organization. Our very first mention of PFHO was 3/19/12, when we added it to our Tier 1 Pink screen. […]
There is no excerpt because this is a protected post.
Ibio (AMEX:IBIO) Price Movement From Ebola/Enterovirus Hype Ibio (AMEX:IBIO) ($1.47) is a leading provider of plant-based biotechnology for developing and manufacturing biological products. As expected, the hype surrounding the Ebola and Enterorvirus outbreaks in the U.S. will inevitably led to aggressive share price […]
Summary REPR’s flagship product has a firm grip on the growing infusion homecare market and REPR’s stock is trading at a significant discount to what it’s worth. The product is held in high regard by those in the industry, who […]
Call(s) to Action: None Here are the stories that the GeoTeam is following today… (Please see full disclosures at bottom) ChinaHybrids VNET ($18.21; marked up pre market) – Announced that Windows Azure services’ WebDirect payment services are now available to […]
There is no excerpt because this is a protected post.
Sciclone Pharmaceuticals (NASDAQ:SCLN)($6.79) – and its partner BTG plc (LSE: BTG), today announced, that the China Food and Drug Administration has approved the registration of DC Bead for the embolization of malignant hypervascularized tumors. BTG and SciClone previously entered into […]